Breaking Update
Israeli Biotech CollPlant Opens U.S. Hub to Expand rhCollagen Distribution
Israeli biotech CollPlant opens U.S. hub to expand rhCollagen distribution. New facility to enhance North American presence with cGMP compliance and AI
Jerusalem, 27 October, 2025 (TPS-IL) — Israeli regenerative medicine company CollPlant Biotechnologies is expanding its North American footprint with a new U.S. logistics hub to distribute its recombinant human collagen (rhCollagen) and BioInk products. Set to become operational this quarter, the facility offers cGMP-compliant storage, clinical supply services, AI-powered security, and cloud-based temperature monitoring.
CEO Yehiel Tal said the hub “demonstrates our long-term commitment to the North American market” and will reduce shipping times while maintaining local inventory.
